Interaction of Sp1 with the human gamma globin promoter: binding and transactivation of normal and mutant promoters.

Abstract:

:We have analyzed the binding of Sp1, a ubiquitously expressed transactivator, to the promoter region of the gamma genes. Low-affinity Sp1 sites were found at -50 and -200. A high-affinity site was detected at -140, over the CACCC sequence. To analyze the function of these sites, Drosophila SL-2 cells, which lack Sp1, were cotransfected with an Sp1 expression plasmid and gamma globin promoter-CAT constructs. In these assays, the gamma promoter was significantly stronger in the presence than in the absence of Sp1. Thus, the three Sp1 sites in the gamma promoter allow binding as well as transactivation of the promoter. The majority of this transactivation was due to the strong binding site at -140 because introduction of a point mutation at -144 (CACCC----AACCC) reduced Sp1-dependent promoter strength by 57%. Analysis of the -200 region suggested that in the wild-type promoter, Sp1 binding at this site contributes little to promoter strength. However, a point mutation (-198 T----C) associated with hereditary persistence of fetal hemoglobin (HPFH) dramatically increased the affinity of this site for Sp1 and significantly increased Sp1 dependent promoter strength in SL-2 cells. Three other point mutations associated with HPFH did not significantly affect the interaction of Sp1 with the -200 region.

journal_name

Blood

journal_title

Blood

authors

Gumucio DL,Rood KL,Blanchard-McQuate KL,Gray TA,Saulino A,Collins FS

subject

Has Abstract

pub_date

1991-10-01 00:00:00

pages

1853-63

issue

7

eissn

0006-4971

issn

1528-0020

journal_volume

78

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Plasma membrane sequestration of apoptotic protease-activating factor-1 in human B-lymphoma cells: a novel mechanism of chemoresistance.

    abstract::Burkitt lymphoma (BL) is a highly aggressive B-cell neoplasm harboring chromosomal rearrangements of the c-myc oncogene. BL cells frequently resist apoptosis induction by chemotherapeutic agents; however, the mechanism of unresponsiveness has not been elucidated. Here, we show that cytochrome c fails to stimulate apop...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-10-4075

    authors: Sun Y,Orrenius S,Pervaiz S,Fadeel B

    更新日期:2005-05-15 00:00:00

  • The interphase microtubule damage checkpoint defines an S-phase commitment point and does not require p21(waf-1).

    abstract::Cell cycle checkpoints ensure orderly progression of events during cell division. A microtubule damage (MTD)-induced checkpoint has been described in G(1) phase of the cell cycle (G(1)MTC) for which little is known. The present study shows that the G(1)MTC is intact in activated T lymphocytes from mice with the p21(wa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.5.1505

    authors: Mantel CR,Braun SE,Lee Y,Kim YJ,Broxmeyer HE

    更新日期:2001-03-01 00:00:00

  • The effect of Hydrocortisone on the kinetics of normal human lymphocytes.

    abstract::Lymphocyte kinetic studies employing 51-chromium-labeled autologous lymphocytes were performed in nine normal volunteers in order to determine the effects of hydrocortisone administration on the recirculating versus the nonrecirculating intravascular lymphocyte pools. Following infusion of labeled cells, the recircula...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fauci AS,Dale DC

    更新日期:1975-08-01 00:00:00

  • Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage.

    abstract::The cytokine interleukin-10 (IL-10) has been implicated in the pathogenesis of a number of disease states, including Epstein-Barr virus and human immunodeficiency virus (HIV-1) infections. In the acquired immunodeficiency syndrome (AIDS), it has been suggested that IL-10 may have a deleterious effect by suppressing ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Saville MW,Taga K,Foli A,Broder S,Tosato G,Yarchoan R

    更新日期:1994-06-15 00:00:00

  • Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.

    abstract::Hemoglobin E (HbE) β-thalassemia is the most common severe thalassemia syndrome across Asia, and millions of people are carriers. Clinical heterogeneity in HbE β-thalassemia is incompletely explained by genotype, and the interaction of phenotypic variation with hepcidin is unknown. The effect of thalassemia carriage o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-10-606491

    authors: Jones E,Pasricha SR,Allen A,Evans P,Fisher CA,Wray K,Premawardhena A,Bandara D,Perera A,Webster C,Sturges P,Olivieri NF,St Pierre T,Armitage AE,Porter JB,Weatherall DJ,Drakesmith H

    更新日期:2015-01-29 00:00:00

  • How we manage autologous stem cell transplantation for patients with multiple myeloma.

    abstract::An estimated 22 350 patients had multiple myeloma diagnosed in 2013, representing 1.3% of all new cancers; 10 710 deaths are projected, representing 1.8% of cancer deaths. Approximately 0.7% of US men and women will have a myeloma diagnosis in their lifetime, and with advances in therapy, 77 600 US patients are living...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2014-03-544759

    authors: Gertz MA,Dingli D

    更新日期:2014-08-07 00:00:00

  • The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice.

    abstract::The transcription factor c-Maf is extensively involved in the pathophysiology of multiple myeloma (MM), a fatal malignancy of plasma cells. In the present study, affinity chromatography and mass spectrometry were used to identify c-Maf ubiquitination-associated proteins, from which the E3 ligase HERC4 was found to int...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-07-658203

    authors: Zhang Z,Tong J,Tang X,Juan J,Cao B,Hurren R,Chen G,Taylor P,Xu X,Shi CX,Du J,Hou J,Wang G,Wu D,Stewart AK,Schimmer AD,Moran MF,Mao X

    更新日期:2016-03-31 00:00:00

  • Human neutrophils mediate trogocytosis rather than phagocytosis of CLL B cells opsonized with anti-CD20 antibodies.

    abstract::Polymorphonuclear neutrophils (PMNs) have previously been reported to mediate phagocytosis of anti-CD20-opsonized B cells from patients with chronic lymphocytic leukemia (CLL). However, recent data have suggested that PMNs, like macrophages, can also mediate trogocytosis. We have performed experiments to more precisel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-08-735605

    authors: Valgardsdottir R,Cattaneo I,Klein C,Introna M,Figliuzzi M,Golay J

    更新日期:2017-05-11 00:00:00

  • Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.

    abstract::The combination of imatinib with chemotherapy has been recently reported as very promising in patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). During 2004 and 2005, 45 patients with newly diagnosed Ph+ ALL were treated in the Group for Research on Adult Acute Lymphoblastic Leuke...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2006-03-011908

    authors: de Labarthe A,Rousselot P,Huguet-Rigal F,Delabesse E,Witz F,Maury S,Réa D,Cayuela JM,Vekemans MC,Reman O,Buzyn A,Pigneux A,Escoffre M,Chalandon Y,MacIntyre E,Lhéritier V,Vernant JP,Thomas X,Ifrah N,Dombret H,Group

    更新日期:2007-02-15 00:00:00

  • Complement-induced regulatory T cells suppress T-cell responses but allow for dendritic-cell maturation.

    abstract::Concurrent activation of the T-cell receptor (TCR) and complement regulator CD46 on human CD4+ T lymphocytes induces Tr1-like regulatory T cells that suppress through IL-10 secretion bystander T-cell proliferation. Here we show that, despite their IL-10 production, CD46-induced T-regulatory T cells (Tregs) do not supp...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-07-2951

    authors: Barchet W,Price JD,Cella M,Colonna M,MacMillan SK,Cobb JP,Thompson PA,Murphy KM,Atkinson JP,Kemper C

    更新日期:2006-02-15 00:00:00

  • Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation.

    abstract::Patients with disseminated follicular non-Hodgkin's lymphoma (NHL) are only occasionally cured with standard chemotherapy regimens. Although most of these tumors are initially responsive to chemotherapy, in 40% to 70% of patients the lymphoma will eventually transform to an NHL of higher grade malignancy and a poorer ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schouten HC,Bierman PJ,Vaughan WP,Kessinger A,Vose JM,Weisenburger DD,Armitage JO

    更新日期:1989-11-15 00:00:00

  • Reversing anti-factor Xa agents and the unmet needs in trauma patients.

    abstract::Andexanet alfa, a reversing agent for anticoagulants that inhibit factor Xa, has recently been licensed in the United States. We discuss the impact of this licensure on current practice and review in detail the problems of a neglected and growing clinical area: reversing the anticoagulation effect of factor Xa inhibit...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2018-06-850396

    authors: Hunt BJ,Neal MD,Stensballe J

    更新日期:2018-12-06 00:00:00

  • Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation.

    abstract::Activation of endothelial cells, important in processes such as angiogenesis, is regulated by cell surface receptors, including those in the tyrosine kinase (RTK) family. Receptor activity, in turn, can be modulated by phosphorylation, turnover, or proteolytic release of a soluble extracellular domain. Previously, we ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yabkowitz R,Meyer S,Black T,Elliott G,Merewether LA,Yamane HK

    更新日期:1999-03-15 00:00:00

  • Rabbit reticulocyte coated vesicles carrying the transferrin-transferrin receptor complex: I. Purification and partial characterization.

    abstract::Coated vesicles bearing the transferrin-transferrin receptor complex were isolated from rabbit reticulocytes by freeze-thaw cell lysis, followed by differential centrifugation with pelleting of vesicles at 100,000 g. Electronmicroscopy demonstrated the vesicles to have the characteristic morphology of coated vesicles,...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Choe HR,Moseley ST,Glass J,Nunez MT

    更新日期:1987-10-01 00:00:00

  • Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.

    abstract::Atypical hemolytic uremic syndrome (aHUS) is a severe renal disease that is associated with defective complement regulation caused by multiple factors. We previously described the deficiency of factor H-related proteins CFHR1 and CFHR3 as predisposing factor for aHUS. Here we identify in an extended cohort of 147 aHUS...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-109876

    authors: Józsi M,Licht C,Strobel S,Zipfel SL,Richter H,Heinen S,Zipfel PF,Skerka C

    更新日期:2008-02-01 00:00:00

  • Tissue-type plasminogen activator (t-PA) induces stromelysin-1 (MMP-3) in endothelial cells through activation of lipoprotein receptor-related protein.

    abstract::Tissue-type plasminogen activator (t-PA) is approved for treatment of ischemic stroke patients, but it increases the risk of intracranial bleeding (ICB). Previously, we have shown in a mouse stroke model that stromelysin-1 (matrix metalloproteinase-3 [MMP-3]) induced in endothelial cells was critical for ICB induced b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-203919

    authors: Suzuki Y,Nagai N,Yamakawa K,Kawakami J,Lijnen HR,Umemura K

    更新日期:2009-10-08 00:00:00

  • Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy.

    abstract::This 2-part, double-blind, placebo-controlled study was conducted to determine the safety and efficacy of etoricoxib, a COX-2 selective inhibitor, for the treatment of hemophilic arthropathy. In part 1 (6 weeks), 102 patients (> or = 12 years old) with hemophilic arthropathy were randomized to receive 90 mg etoricoxib...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2004-09-3501

    authors: Tsoukas C,Eyster ME,Shingo S,Mukhopadhyay S,Giallella KM,Curtis SP,Reicin AS,Melian A

    更新日期:2006-03-01 00:00:00

  • The active monomeric form of macrophage inflammatory protein-1 alpha interacts with high- and low-affinity classes of receptors on human hematopoietic cells.

    abstract::Macrophage inflammatory protein-1 alpha (MIP-1 alpha) and its human homologue GOS19.1/LD78 are members of the C-C chemokine/intercrine family of secreted proteins. They have proinflammatory properties and also inhibit cell cycle progression of hematopoietic stem cells. Characterization of MIP-1 alpha receptor(s) has b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Avalos BR,Bartynski KJ,Elder PJ,Kotur MS,Burton WG,Wilkie NM

    更新日期:1994-09-15 00:00:00

  • Prognostic significance of Bax protein expression in diffuse aggressive non-Hodgkin's lymphoma.

    abstract::Bax is a proapoptotic member of the Bcl-2 protein family. The incidence and prognostic significance of Bax protein expression in diffuse non-Hodgkin's lymphomas with a large cell component (DLCL) was determined by an immunohistochemical method by using paraffin-embedded tumors from a cohort of patients treated uniform...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gascoyne RD,Krajewska M,Krajewski S,Connors JM,Reed JC

    更新日期:1997-10-15 00:00:00

  • Crosstalk between RANKL and Fas signaling in dendritic cells controls immune tolerance.

    abstract::Although receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) signaling has been shown to prolong the survival of mature dendritic cells (DCs), the association of RANKL pathway with Fas-mediated apoptosis is obscure. Here, we found that bone marrow-derived DCs (BMDCs) from the Fas-deficient strain MRL/lpr m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-11-059980

    authors: Izawa T,Ishimaru N,Moriyama K,Kohashi M,Arakaki R,Hayashi Y

    更新日期:2007-07-01 00:00:00

  • The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis.

    abstract::Cancer is a leading cause of thrombosis. We identify a new procoagulant mechanism that contributes to thromboembolism in prostate cancer and allows for safe anticoagulation therapy development. Prostate cancer-mediated procoagulant activity was reduced in plasma in the absence of factor XII or its substrate of the int...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-01-622811

    authors: Nickel KF,Ronquist G,Langer F,Labberton L,Fuchs TA,Bokemeyer C,Sauter G,Graefen M,Mackman N,Stavrou EX,Ronquist G,Renné T

    更新日期:2015-09-10 00:00:00

  • Notch ligands Delta 1 and Jagged1 transmit distinct signals to T-cell precursors.

    abstract::Signaling through the Notch pathway plays an essential role in inducing T-lineage commitment and promoting the maturation of immature thymocytes. Using an in vitro culture system, we show that 2 different classes of Notch ligands, Jagged1 or Delta1, transmit distinct signals to T-cell progenitors. OP9 stromal cells ex...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-08-3257

    authors: Lehar SM,Dooley J,Farr AG,Bevan MJ

    更新日期:2005-02-15 00:00:00

  • Impact of CTLA4 genotype and other immune response gene polymorphisms on outcomes after single umbilical cord blood transplantation.

    abstract::We evaluated the impact of recipient and cord blood unit (CBU) genetic polymorphisms related to immune response on outcomes after unrelated cord blood transplantations (CBTs). Pretransplant DNA samples from 696 CBUs with malignant diseases were genotyped for NLRP1, NLRP2, NLRP3, TIRAP/Mal, IL10, REL, TNFRSF1B, and CTL...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-06-722249

    authors: Cunha R,Zago MA,Querol S,Volt F,Ruggeri A,Sanz G,Pouthier F,Kogler G,Vicario JL,Bergamaschi P,Saccardi R,Lamas CH,Díaz-de-Heredia C,Michel G,Bittencourt H,Tavella M,Panepucci RA,Fernandes F,Pavan J,Gluckman E,Roch

    更新日期:2017-01-26 00:00:00

  • Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.

    abstract::Acute erythroleukemia (AEL or acute myeloid leukemia [AML]-M6) is a rare but aggressive hematologic malignancy. Previous studies showed that AEL leukemic cells often carry complex karyotypes and mutations in known AML-associated oncogenes. To better define the underlying molecular mechanisms driving the erythroid phen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003062

    authors: Fagnan A,Bagger FO,Piqué-Borràs MR,Ignacimouttou C,Caulier A,Lopez CK,Robert E,Uzan B,Gelsi-Boyer V,Aid Z,Thirant C,Moll U,Tauchmann S,Kurtovic-Kozaric A,Maciejewski J,Dierks C,Spinelli O,Salmoiraghi S,Pabst T,Shimo

    更新日期:2020-08-06 00:00:00

  • Inhibition of Akt increases p27Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphoma.

    abstract::Anaplastic large cell lymphoma (ALCL) is a highly proliferative neoplasm that frequently carries the t(2;5)(p23;q35) and aberrantly expresses nucleophosmin-anaplastic lymphoma kinase (NPM-ALK). Previously, NPM-ALK had been shown to activate the phosphatidylinositol 3 kinase (PI3K)/Akt pathway. As the cyclin-dependent ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-06-2125

    authors: Rassidakis GZ,Feretzaki M,Atwell C,Grammatikakis I,Lin Q,Lai R,Claret FX,Medeiros LJ,Amin HM

    更新日期:2005-01-15 00:00:00

  • Anomalous function of vimentin in chronic lymphocytic leukemia lymphocytes.

    abstract::Chronic lymphocytic leukemia (CLL) lymphocytes manifest anomalous motility and cap formation. Since these processes involve cytoskeletal proteins, vimentin from intermediate filaments of normal and CLL lymphocytes was investigated using hetero- and monoclonal antisera. The antisera reacted predominantly with a 60-kD p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Stark RS,Liebes LF,Shelanski ML,Silber R

    更新日期:1984-02-01 00:00:00

  • Progression and survival studies in early chronic lymphocytic leukemia.

    abstract::To investigate the natural history of stage A chronic lymphocytic leukemia (CLL) we reviewed 84 such patients. Among 74 cases evaluable for disease progression, 22 (29.6%) progressed to more advanced clinical stages (9 to stage B, 13 to stage C); the actuarial estimation of such an event at 4 years was 30% (95% CI: 26...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Molica S

    更新日期:1991-08-15 00:00:00

  • The proportion of mitoses in different cell lineages changes during short-term culture of normal human bone marrow.

    abstract::To determine the hematopoietic cell lineage of mitotic cells in human bone marrow on direct examination and after 24-hour culture, marrow mitoses from four healthy individuals were studied, using a new technique that allows analysis of karyotypes in cells whose cell membrane and cytoplasm have been preserved. Mitoses ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Keinänen M,Knuutila S,Bloomfield CD,Elonen E,de la Chapelle A

    更新日期:1986-05-01 00:00:00

  • Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011.

    abstract::The effect of recombinant factor VIII (rFVIII) brand on inhibitor development was investigated in all 407 severe hemophilia A previously untreated patients born in the United Kingdom (UK) between 1 January 2000 and 31 December 2011. Eighty-eight (22%) had been in the RODIN study. Information was extracted from the Nat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-580498

    authors: Collins PW,Palmer BP,Chalmers EA,Hart DP,Liesner R,Rangarajan S,Talks K,Williams M,Hay CR,UK Haemophilia Centre Doctors’ Organization.

    更新日期:2014-11-27 00:00:00

  • Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis.

    abstract::Allogeneic hematopoietic cell transplantation in multiple myeloma is limited by prior reports of high treatment-related mortality. We analyzed outcomes after allogeneic hematopoietic cell transplantation for multiple myeloma in 1207 recipients in 3 cohorts based on the year of transplantation: 1989-1994 (n = 343), 199...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-337329

    authors: Kumar S,Zhang MJ,Li P,Dispenzieri A,Milone GA,Lonial S,Krishnan A,Maiolino A,Wirk B,Weiss B,Freytes CO,Vogl DT,Vesole DH,Lazarus HM,Meehan KR,Hamadani M,Lill M,Callander NS,Majhail NS,Wiernik PH,Nath R,Kamble RT

    更新日期:2011-08-18 00:00:00